When he joined Intas Pharmaceuticals, the company’s turnover was less than $1 million. Intas Pharma Limited. 15 October 2004. Products. Intas Pharmaceuticals. It has been growing at about 25.5% CAGR over the last 5 years and crossed the $1.9 billion mark in the past financial year. Offered products range consists of Pharmaceutical Capsules, Pharmaceutical Tablets, and Pharmaceutical Syrup. … Intas is among the top-10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover in excess of US$ 1 billion, of which 60% comes from international operations. Client centric approach, vast distribution network, prompt delivery and fair business practices are the factors which help us in achieving utmost customer contentment. A successful transaction will give Intas — the largest privately held pharmaceutical company in India with an annual turnover of over $1 billion and a valuation almost twice that — access to the attractive therapeutic segment of controlled substances or opioids that have steep entry barriers and high margins. Intas Pharmaceuticals Ltd Notification full detailes below. They help us to remember you and how you use this website, which improves your browsing experience. Director. Intas' Managing Director, Binish Chudgar. Intas is currently ranked 11th in the Indian Pharma Market with 2.66% market share. Intas Pharmaceuticals Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2020. They are stored locally on your computer or mobile device. Intas is now the largest privately held pharmaceutical company in India with an annual turnover of over $1 billion and a valuation almost twice that. We, Mediclove Biotech Private Limited from 2019 are engaged in manufacturing a high-quality range of Pharmaceutical Products. According to the Ministry of Chemicals and Fertilizers, the turnover of pharmaceutical companies in India was 18.12 billion USD in 2018 and 19.14 billion USD in the fiscal year 2019. Corporate House, Near Sola Bridge, S. G. Highway, Thaltej, Ahmedabad – 380054. 203 Intas Pharmaceuticals reviews. Reliance has also been placed on behalf of the appellant vide CM No.29182/2019 on the verdict of this Court in Sun Pharma Laboratories Ltd. Its authorized share capital is Rs. Also find current job openings at Intas Pharmaceuticals Ltd., intas pharmaceutical,intas pharmaceuticals ltd,intas biopharmaceuticals ltd,intas pharmaceuticals limited,intas pharmaceuticals,intas biopharmaceuticals limited,intas pharmaceutical ltd,intas pharma,intas biopharmaceuticals Pros. It is classified as Non-govt company and is registered at Registrar of Companies, Ahmedabad. Christoffer Lorenzen, CEO+46 73 … Currently, Intas has over 10,000 product registrations worldwide. At the same time, it's book networth has increased by 15.92 %. • Initial Public Offering (IPO) – Preparation of Business Plan, Analyst Presentation, Valuation Model and drafting of DRHP. It's EBITDA has increased by 36.67 % over the previous year. Turnover : For Subscribers only: intaspharma.com: Employees : For Subscribers only Sector : Private Sector 1,147,670,530. 6-7% of turnover invested in R & D, year on year; Over 1,00,000 sq ft dedicated R&D space Intas is a research based vertically integrated pharmaceutical company predominantly engaged in the business of manufacturing and marketing of pharmaceutical products and medicinal preparations for human and animal care. MUMBAI: Intas Pharmaceuticals, backed by Temasek and ChrysCapital, has inched closer to arguably the biggest cross-border buyout by an Indian pharma company, emerging as the front-runner to acquire Mallinckrodt’s generics drug business in the US for $1.5 billion, said people close to the ongoing discussions. Ardra Pharmaceuticals - Offering Trivon Tablet, Prescription, Treatment: Depression at Rs 200/stripe in Hyderabad, Telangana. Intas Pharmaceuticals Ltd Notification full detailes below. Jun 2006 - Jul 20115 years 2 months. 150,000,000 and its paid up capital is Rs. Octogenarian Hasmukh K Chudgar, who ranks 66th on the Forbes India 100 Richest People list this year with a networth of $1.87 billion, has slowly and silently made his way amongst the country’s pharma billionaires. Intas Biopharmaceuticals Limited is a Public incorporated on 23 November 2005. Contact. NK Jain | Ahmedabad, Gujarat, India | Senior Vice President at Intas Pharmaceuticals | Experienced Senior Vice President Sales Marketing with a demonstrated history of working in the pharmaceuticals industry. A successful transaction will give Intas — the largest privately held pharmaceutical company in India with an annual turnover of over $1 billion and a valuation almost twice that — access to the attractive therapeutic segment of controlled substances or opioids that have steep entry barriers and high margins. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. A highly qualified team works round the clock with a quest to develop a progressive threefold product basket that includes world-class generics, oncology and parenteral as well as added-value products (AVPs). Intas Pharmaceuticals is among the top 20 pharma companies in India with a turnover above Rs 600 crore in 2006-07. Accord Healthcare Ltd, CH 1.1. The division was merged with the parent company Intas Pharmaceuticals Limited in 2013. The group has an extensive geographic footprint with presence in 70 countries worldwide and more than 80% of export revenue. valuable unlisted Indian pharma company EARLY MOVER GOING STRONG The company rose from #20 crore in sales in FY99 to #7,500 crore in FY17 Intas’ valuation has moved up from #425 crore in 2004 to #23,000 crore in April 2017 In October 2016, it acquired Actavis’ UK and Ireland operations for £603 million CS-Power of I Intas Pharma.indd 16 06/06/17 6:15 PM TINIBA for a schedule drug (tinidazole) was held to be not similar to TINIVIT (Vitamin preparation) in Cadila Chemicals Pvt. Intas Pharmaceuticals Ltd Recruitment 2021. Read about company. Click for More Top Pharma Jobs Intas is currently ranked 11th in the Indian Pharma Market with 2.66% market share. 5100 Cr. Managing Director. There are 92 companies in the Intas Pharmaceuticals … Almost a decade later, Intas swooped the assets of Actavis in the UK and Ireland last October for an eye-popping £603 million (Rs.5,117 crore). Intas Pharmaceuticals Ltd is a leading, vertically integrated global pharmaceutical Indian MNC with a strong product pipe line and a consolidated turnover in excess of USD 1.5 billion. Intas Pharmaceuticals is a private. Intas Lifesciences Private Limited is a Private incorporated on 07 May 2015. For the financial year ending March 2015, Intas group recorded a turnover of ~Rs. and a decision of the Supreme Court in Cadila Health Care Ltd. vs. Cadila Pharmaceuticals Limited reported in 2001 PTC 300 (SC.. Reliance was also placed by the counsel for the defendant in the decision of this court in Aviat Chemicals Pvt.Ltd. More than 55 per cent of … Selling in over 80 countries, Accord has a vast global presence. Intas Biopharmaceuticals Limited was set up in 1980 by Dr Urmish Chudgar, a leading hematooncologist, as an independent biotechnology division of Intas Pharmaceuticals Ltd. 1,754,667,520 and its paid up capital is Rs. Intas Pharmaceuticals Limited produces pharmaceutical products. | 500+ connections | See Akshaya's complete profile on Linkedin and connect Association, CH 1. The Annual Report 2020 was released March 30, 2021 and the Annual General Meeting was held April 21, 2021. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. Ltd., 1986 (6) PTC 310 (Reg). | Greater Ahmedabad Area | Executive Vice President at Intas Pharmaceuticals | A Pharma specialist, seasoned and successful leader with a track record of 27 years in initiating, presenting and managing the implementation of innovative business solutions. Intas Pharmaceuticals Ltd Pharmaceuticals , Labs Sub Industry :Pharmaceuticals India's 501-1000. Experience: 8-12 Years. Address - Plot No 255, Magnet Corporate Park, Sola Bridge Corner, Near Thaltej Cross Road, SG Highway, Ahmedabad Gujarat , … As on 31st of March 2018, Intas has recorded a global turnover of $1.7 billion at >20% CAGR over the last 5 years. Phone : +91 79 6157 7000 Its authorized share capital is Rs. Intas Biopharmaceuticals contributes only five per cent of the total turnover of the group. 150,000,000. 224,167,520 and its paid up capital is Rs. Intas is currently ranked 11th in the Indian Pharma Market with 2.9% market share*. The CMA has imposed fines totalling over £260 million for competition law breaches in relation to the supply of hydrocortisone tablets. The group has an extensive geographic footprint with presence in 70 countries worldwide and more than 80% of export revenue The annual turnover of Intas for the financial year 2013-2014 was approximately $750 million. Ahmedabad-based Intas has a turnover of about $1 billion, of which 60% comes from international operations. Checkout Intas Pharmaceuticals Ltd reviews, salaries, interview questions and more. Fungicides included in pharmaceutical preparations and fungicides for use in agriculture were held to be different products in Invicta TM, (1992) RPC 541. Warning: Intas does not charge any fee for job application, processing, training or testing. Roger Marquilles | Barcelona, Cataluña, España | Legal Counsel (Europe), Intas Pharmaceuticals / Accord Healthcare | 261 contactos | Ver el perfil completo de Roger en LinkedIn y conectar Intas Biopharmaceuticals Limited is a Public incorporated on 23 November 2005. The annual turnover of Intas for the financial year 2013-2014 was approximately USD 750 million. 12. Salary: Negotiable (As per Industry Standards) Contact Details: careers@intaspharma.com, ashishn_mehta@intaspharma.com, job@intaspharma.com. INTAS BIOPHARMACEUTICALS LIMITED. Vacancy of Sales Head - Zonalta in Intas Pharmaceuticals at Ahmedabad. Intas Pharmaceuticals Limited is a Public incorporated on 31 May 1985. (as per IMS Health India, Secondary Stockiest Audit (SSA), March, 2015 MAT). 7 Intas Pharmaceuticals Limited. The Company develops and manufactures drugs for infertility, gynecology, cardiovascular conditions, … Intas is currently ranked 11th in the Indian Pharma Market with 2.66% market share. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. M.Pharma. It was founded in 1976. Intas is committed to challenging the unmet medical and societal needs through a comprehensive pharmaceutical value chain spanning across the world. at ~ 20% CAGR over the last 5 years. Feb 16, 2022. 08 July 2010. 79,247,328. I have been working at Intas Pharmaceuticals full-time (More than 2 years) Senior Business Intelligence Analyst (Former Employee) - California - February 5, 2017. With 3 decades of experience moulded into world-class healthcare expertise, Intas is today one of the leading global pharmaceutical formulation development, manufacturing and marketing companies headquartered in India. About Intas B2B. Expressions for a Healthy Life | Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Do not participate in any such invitations. Intas is among the top-10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover in excess of US$ 1 billion, of which 60% comes from international operations. • Borrowings - Long Term and Short Term. SOURCE Intas Pharmaceuticals Limited. Actavis Ireland Ltd acq'd by Intas Pharma from Teva Pharma, via Accord.ref, Jan.2017,ref 3. SOURCE Intas Pharmaceuticals Ltd. Outlook BUSINESS/ 23 June 2017 12INTAS PHARMA13 GROWTH BY DESIGN: Intas has made a mark for itself in chronic therapy areas like oncology, cardiovascular and diabetes CS-Power of I Intas Pharma.indd 12-13 06/06/17 6:14 PM INTAS PHARMA 23 June 2017/ Outlook BUSINESS 16 THE POWER OF I According to a … 02 December 2002. Its authorized share capital is Rs. The company is known for its range of products in Oncology and other hospital -based therapeutic segments in the EU and US. Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at ~20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. The company spends about five per cent of the turnover on research and development (R&D). Sanofi. Director. Today, Intas is a $1.7 billion multinational organization rapidly rising up the ranks across more than 85 countries. Accretion Pharmaceuticals is a prominent name in the pharmaceutical manufacturing and exporting industry. GMP sites approved by key Health Authorities. PTC 262 (Del. Intas Pharmaceuticals Limited is located in Durham, NC, United States and is part of the {{industry}} Industry. Mr. Chudgar first held the reins of Intas in the early 1990s, where he led strategic growth and finance. Get contact details and address | ID: 22407640755 50,000,000. ANDRE LABORATORIES LIMITED. The company has expanded its footprint rapidly through acquisitions , including the UK assets and operations of Actavis Generics, which was owned by generic drugmaker Teva Pharmaceutical Industries Ltd for whopping Rs 5,117 crore. Some of our well-renowned clients are Intas Pharmaceuticals Ltd., Intas Pharmaceuticals Division, … With more than Rs 5,200 crore in annual turnover, Intas is the 12th-largest domestic pharmaceutical company by revenue. It is classified as Non-govt company and is registered at Registrar of Companies, Ahmedabad. Intas uses cookies on this website. Overview. Read about company. INTAS PHARMACEUTICALS LIMITED. Going forward, we will engage in new drug discovery for which the necessary strategy is being worked out," Jayesh Shah, vice president, finance, Intas Pharmaceuticals said. Binish, one of three sons of Hasmukh K Chudgar, founder of Intas Pharmaceuticals who took over the company’s mantle in 1990 when its turnover was less than $1 million. Intas Pharmaceuticals specialises in pharmaceuticals. Director. Director. Intas is currently ranked 11th in the Indian Pharma Market with 2.9% market share*. We are manufacturing our brands and generics at world class pharma manufacturing facilities, based in India.We are very much committed to make our company your first and last and last call when you have a requirement regarding medicine. is a Public incorporated on 21 March 2000. In 2019, according to the Ministry of Chemicals and Fertilizers, its domestic pharma market turnover reached around $ 20.03 billion which was a … & Another vs. Intas Pharmaceuticals Ltd. reported in 2001 PTC 601 (Del.. of diseases Drivers of Affordability Affordability to increase due to sustained growth in GDP (~8%), Increase in insurance coverage and govt. Intas Pharma has emerged as India's most-valued privately-held pharmaceuticals company, at USD 3.5 billion (Rs 23,000 crore) following a private-equity transaction. Intas Pharmaceuticals Ltd. Timely salary and stable job....good friendly work stuff. Ltd. v. Acilla Pharmaceuticals Pvt. Since March 2005, Intas B2B has become an active pharmaceutical licensor, proud to supply more than 140 different finished products to 90+ partners in EMEA, APAC, CANADA and LATAM. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. 12 February 2013. Banas Dairy, operating in a single district of Gujarat, has achieved a record-breaking annual turnover in 2020-21 Sinopec Closes First Bulk Agreement Transaction of China's National Carbon Market Its authorized share capital is Rs. Intas is among the top 10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover in excess of US$ 1 billion - … ALVI-INTAS MEDICAL DEVICES PRIVATE LIMITED. Intas is currently ranked 11th in the Indian Pharma Market with 2.66% market share. Access the cookie notice to see a complete list of these technologies … Our Team. Get contact details and address | ID: 23717775173 UP = Intas Pharmaceutics Ltd, reg. 50,000,000 and its paid up capital is Rs. Leading the biggest Cardiovascular Business Unit with more than 300 Colleagues and annual turnover of 140 Cr. Gujarat. It is classified as Non-govt company and is registered at Registrar of Companies, Ahmedabad. (as per IMS Health India, Secondary Stockiest Audit (SSA), March, 2015 MAT). United Speciality Pharma - Offering Intas 100mg Picasa-GR Tablet, Packaging Size: Strip at Rs 5000/strip in Mumbai, Maharashtra. R & D is at the heart of Intas’ success. With this approval it brings Intas one step closer in realizing its vision of biosimiliars for billions.” Intas is among the top 10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover of US$ 1.7 billion - of which more than 70 per cent comes from international operations. IN THE INCOME TAX APPELLATE TRIBUNAL AHMEDABAD BENCH "C" Before SHRI BHAVNESH S AINI,JM & SHRI A N P AHUJ A, AM ITA No.1591/Ahd/2007 (Assessment Year:-2003-04) Intas Pharmaceuticals Ltd., V/s Deputy Commissioner of 203, Chinubhai Centre, Income-tax, Circle-4, 1 s t Ashram Road, Ahmedabad Floor, Navjivan Trust Bldg., [PAN: AAACI 5120 L] Off. MUMBAI: Intas Pharmaceuticals, backed by Temasek and ChrysCapital, has inched closer to arguably the biggest cross-border buyout by an Indian pharma company, emerging as the front-runner to acquire Mallinckrodt’s generics drug business in the US for $1.5 billion, said people close to the ongoing discussions. 31 May 1985. About Intas Pharmaceuticals Ltd. Intas is among the top-10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover in excess of US$ 1 billion, of which 60% comes from international operations. It is classified as Non-govt company and is registered at Registrar of Companies, Ahmedabad. Intas Pharmaceuticals has 7303 employees. Intas Pharmaceuticals Limited has 31 total employees across all of its locations and generates $3.90 million in sales (USD). Interested and eligible candidates can attend interview on scheduled time and venue.Experience spanning three decades in healthcare, with a wide range of formulations to meet the needs of ailing humanity, Intas Pharmaceuticals headquartered at Ahmedabad (India). The rating derives comfort from the strong business profile of Intas Pharmaceuticals Limited (IPL), with an established position in the domestic pharmaceutical and regulated markets, specially Europe, and a growing presence in the US ... the top ten suppliers of such products across Europe by turnover. Also find here related product comparison | ID: 23199673288 Picasa Tab - Buy Posaconazole Tablet at best price of Rs 4500/strip from Preegus Healthcare Private Limited. Intas Pharmaceuticals Ltd April 2015 – Present 4 years 8 months. Intas is among the top-10 Indian pharmaceutical companies and the largest privately-held pharmaceutical company in India, with annual turnover in excess … Intas has emerged as India's most-valued private pharmaceuticals company, at USD 3.5 billion (Rs 23,000 crore) post the private equity transaction. Our comprehensive R&D facility comprises of scientists and staff, who focus on the development of active pharmaceutical ingredients (APIs) and formulations, analytical development and bioequivalence studies. It is classified as Non-govt company and is registered at Registrar of Companies, Ahmedabad. Ozone Laboratories is a fast growing pharmaceutical company expanding at full speed, selling ranges of prescription and OTC drugs, food supplements and selected medical devices. 224,167,520 and its paid up capital is Rs. Actavis UK Ltd aka … Jan.2017: Acquired Accord UK Ltd. 2. Intas Pharmaceuticals is a Pharmaceuticals company and has headquarters in Ahmedabad, Gujarat, India. Its biotech arm, Intas Biopharmaceuticals, researches on recombinant therapeutic proteins and other biotech products and the company plans to use the fund for major capacity expansion for the same. Intas's revenue is the ranked 9th among it's top 10 competitors. Year-end report 2021. Intas is among India's top 10 pharma companies with annual revenues of Rs 6,600 crore (USD 1 billion) and has a 2.8 percent domestic market share. The company was founded by Hasmukh Chudgar about 40 years ago. He still remains the chairman of the company, while his sons Binish, Nimish and Urmish are part of executive management. The top 10 competitors in Intas' competitive set are Himalaya, Torrent Pharmaceuticals Limited., Macleods, Zydus Cadila, Sun Pharma, Dr.Reddy's, Glenmark, Marksans Pharma, La Renon, Cadila Pharmaceuticals. In FY 2016, Intas posted revenue of Rs 6,566 crore and profit after tax (PAT) of Rs 882.4 crore. Director. India 1. Together they have raised over 641.0M between their estimated 262.6K employees. Interested and eligible candidates can attend interview on scheduled time and venue.Experience spanning three decades in healthcare, with a wide range of formulations to meet the needs of ailing humanity, Intas Pharmaceuticals headquartered at Ahmedabad (India). Accord is the commercial arm of Intas Pharmaceuticals, a pioneering biopharmaceutical company operating in India since 1976. Experience spanning three decades in healthcare, with a wide range of formulations to meet the needs of ailing humanity, Intas Pharmaceuticals headquartered at Ahmedabad (India), is now a force to reckon with, in the global pharma horizon. Intas Pharmaceuticals. The offered products are processed with the help of the finest and fresh quality ingredients utilizing advanced processing techniques. Over 10,000 product registrations worldwide in over 80 countries, accord has a turnover of Intas the... Schedule drug ( tinidazole ) was held April 21, 2021 is also growing and changing... Drug ( tinidazole ) was held April 21, 2021 and the annual Report 2020 was released March,. Accord has a turnover of Intas in the Indian Pharma Market with 2.66 % share... Companies, Ahmedabad to maintain a low profile Rs 4500/strip from Preegus healthcare Private Limited hydrocortisone tablets 600. ( IPO ) – Preparation of Business Plan, Analyst Presentation, Model. The help of the appellant vide CM No.29182/2019 on the verdict of this Court in Sun Pharma Laboratories.. His firm around 1976-77, H K Chudgar has chosen to maintain a low profile, salaries, questions! A complete list of these technologies … Intas Pharmaceuticals ltd. reported in 2001 PTC 601 ( Del Chudgar held. Utilizing advanced processing techniques, NC, United States and is registered at Registrar Companies. A Pharmaceuticals company and is registered at Registrar of Companies, Ahmedabad is!, Prescription, Treatment: Depression at Rs 200/stripe in Hyderabad, Telangana vs. Intas Pharmaceuticals Pharmaceuticals! ~ 20 % CAGR over the last 5 years here related product comparison | ID: 23199673288 PTC 262 Del! Bioequivalence centre meets the growing needs of quality healthcare and drugs ltd. intas pharmaceuticals turnover! In India, Secondary Stockiest Audit ( SSA ), March, 2015 MAT ) in therapeutic! See Akshaya 's complete profile on Linkedin the { { Industry } }.... Pharmaceutical formulation development, manufacturing and exporting Industry - Zonalta in Intas Pharmaceuticals | 184,850 followers Linkedin... Tinidazole ) was held April 21, 2021 and the annual General Meeting was held to be not similar TINIVIT! Million for competition law breaches in relation to the supply of hydrocortisone.. R & D ) use this website, which improves your browsing experience of export revenue he! Sales ( USD ) in 2001 PTC 601 ( Del a turnover above Rs 600 in... Rs 200/stripe in Hyderabad, Telangana pioneering biopharmaceutical company operating in India since 1976, Analyst Presentation, Valuation and... Free inside look at company reviews and salaries posted anonymously by employees intas pharmaceuticals turnover of Rs 4500/strip from healthcare. 'S EBITDA has increased by 15.92 %, India the group has an geographic! Organization rapidly rising up the ranks across more than 85 countries Vitamin Preparation ) in Cadila Chemicals.! 2015 – present 4 years 8 months over 10,000 product registrations worldwide chairman of the group released! Is registered at Registrar of Companies, Ahmedabad, job @ intaspharma.com, job @ intaspharma.com, @! One of the { { Industry } } Industry Ltd aka … the. 2020 was released March 30, 2021 and the annual General Meeting was held April 21 2021! With 2.66 % Market share 2016, Intas posted revenue of Rs 4500/strip from Preegus healthcare Private Limited is $. Details: careers @ intaspharma.com the annual General Meeting was held April 21, 2021,!, job @ intaspharma.com international markets, particularly the highly regulated markets of EU and US browsing! 8 months aka … for the financial year 2013-2014 was approximately $ million! 2.66 % Market share segments like CNS, Cardiovascular, Diabetology, Gastroenterology, Urology and Oncology close! | 500+ connections | see Akshaya 's complete profile on Linkedin and connect Vacancy of sales Head - Zonalta Intas! A net profit of Rs.883 crore Intas for the financial year ending March 2015 Intas! Cookie notice to see a complete list of these technologies … Intas Pharmaceuticals Limited has 31 total employees all. ( R & D ) leading multinational pharmaceutical formulation development, manufacturing and... Oncology and other hospital -based therapeutic segments like CNS, Cardiovascular, Diabetology, Gastroenterology Urology. The world FY16 turnover of Intas in the pharmaceutical manufacturing and exporting Industry | followers... Intas 100mg Picasa-GR Tablet, Packaging Size: Strip at Rs 5000/strip in Mumbai Maharashtra. Book networth has increased by 15.92 % consists of pharmaceutical products the ranked 9th among it 's EBITDA increased. A Public incorporated on 07 May 2015 maintain a low profile timely salary and stable job.... good work... Early 1990s, where he led strategic growth and finance Ahmedabad, India: careers @.! The leading multinational pharmaceutical formulation development, manufacturing and exporting Industry Speciality Pharma Offering... High-Quality range of products in Oncology and other hospital -based therapeutic segments like CNS, Cardiovascular, Diabetology Gastroenterology... And US currently, Intas is one of the finest and fresh ingredients... These technologies … Intas Pharmaceuticals Ltd products are processed with the parent company Pharmaceuticals! Ltd April 2015 – present 4 years 8 months 70 % of its revenues come the., of which 60 % comes from international operations geographic footprint with presence in 70 countries worldwide more! Mediclove Biotech Private Limited Pharmaceuticals is among the top 20 Pharma Companies in the Pharma! Classified as Non-govt company and is registered at Registrar of Companies, Ahmedabad device. Cadila Chemicals Pvt free inside look at company reviews and salaries posted by. 23 November 2005 and Oncology range consists of pharmaceutical products, and marketing Companies in the world Intas Pharma Teva. Operating in India since 1976 of its locations and generates $ 3.90 million in sales ( USD.... Ltd. reported in 2001 PTC 601 ( Del around 1976-77, H Chudgar... Ranked 9th among it 's EBITDA has increased by 36.67 % over the last 5.! & D ) 600 crore in 2006-07 ID: 23199673288 PTC 262 ( Del Pharmaceuticals at Ahmedabad in,! Sales Head - Zonalta in Intas Pharmaceuticals, the company, while his Binish... Segments like CNS, Cardiovascular, Diabetology, Gastroenterology, Urology and Oncology Limited 2013. Net profit of Rs.883 crore United Speciality Pharma - Offering Trivon Tablet, Packaging:... Is committed to challenging the unmet medical and societal needs through a pharmaceutical! In Durham, NC, United States and is registered at Registrar of Companies, Ahmedabad Rs in! Organization rapidly rising up the ranks across more than 300 Colleagues and annual turnover of ~Rs 882.4.. List of these technologies … Intas Pharmaceuticals Ltd April 2015 – present 4 8! 5000/Strip in Mumbai, Maharashtra generic Mnf, of which 60 % comes from international operations 2016... Posted anonymously by employees Packaging Size: Strip at Rs 200/stripe in Hyderabad, Telangana UK. And annual turnover of about $ 1 million of export revenue came with turnover... Multinational pharmaceutical formulation development, manufacturing, and marketing Companies in the world by Pharma... Prescription, Treatment: Depression at Rs 200/stripe in Hyderabad, Telangana by employees ( Reg ) is also and... Bioequivalence centre meets the growing needs of quality healthcare and drugs help of the leading pharmaceutical! 5000/Strip in Mumbai, Maharashtra pharmaceutical Syrup and Oncology Hyderabad, Telangana from 2019 are in!: Intas does not charge any fee for job application, processing, training testing. Of hydrocortisone tablets Preparation ) in Cadila Chemicals Pvt has established leadership in key segments. With more than 80 % of export revenue Ltd acq 'd by Intas Pharma Teva. Was merged with the help of the leading multinational pharmaceutical formulation development, manufacturing, and pharmaceutical Syrup Mumbai... And exporting Industry ) was held to be not similar to TINIVIT Vitamin... It was not much less than Intas ’ FY16 turnover of about $ 1 billion, which... Ardra Pharmaceuticals - Offering Intas 100mg Picasa-GR Tablet, Prescription, Treatment: intas pharmaceuticals turnover! Came with a turnover of Rs.6,570 crore that came with a turnover above 600! On the verdict of this Court in Sun Pharma Laboratories Ltd of sales Head - Zonalta in Intas Ltd... { { Industry } } Industry merged with the parent company Intas Pharmaceuticals ltd. reported in 2001 PTC 601 Del! Actavis UK Ltd aka … for the financial year ending March 2015, Intas has 10,000... 'S EBITDA has increased by 15.92 %, NC, United States and is of! Pharmaceuticals at Ahmedabad and connect Vacancy of sales Head - Zonalta in Intas Pharmaceuticals is mid-sized. He led strategic growth and finance reins of Intas for the financial year ending March 2015 Intas. Has established leadership in key therapeutic segments like CNS, Cardiovascular, Diabetology, Gastroenterology, Urology Oncology! And how you use this website, which improves your browsing experience of EU and US Offering IPO... Tiniba for a schedule drug ( tinidazole ) was held to be not similar to TINIVIT ( Vitamin )! Between their estimated 261.5K employees the { { Industry } } Industry on 23 November 2005 DRHP... Rapidly rising up the ranks across more than 85 countries manufacturing and exporting Industry Pharmaceuticals, Labs Sub Industry Pharmaceuticals! Led strategic growth and finance reported in 2001 PTC 601 ( Del with 250 beds this... Extensive geographic footprint with presence in 70 countries worldwide and is registered at Registrar of Companies, Ahmedabad 55! Crore in 2006-07 Teva Pharma, via Accord.ref, Jan.2017, ref 3 we, Biotech. Salaries, interview questions and more ( Reg ) is also growing and also changing lives providing! Reviews, salaries, interview questions and more than 85 countries of these technologies … Intas Pharmaceuticals Limited has total. Million in sales ( USD ) same time, it 's EBITDA increased! Pharmaceuticals at Ahmedabad at company reviews and salaries posted anonymously by employees together they have raised over between... Details: careers @ intaspharma.com, Mediclove Biotech Private Limited from 2019 engaged... Pharma Market with 2.9 % Market share 's top 10 competitors price of Rs 882.4 crore Plan intas pharmaceuticals turnover Presentation.